WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014206563) NEW USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/206563    International Application No.:    PCT/EP2014/001736
Publication Date: 31.12.2014 International Filing Date: 26.06.2014
IPC:
A61K 38/17 (2006.01), C07K 14/47 (2006.01), A61K 48/00 (2006.01), C07K 16/40 (2006.01), C12N 15/00 (2006.01), A61P 25/28 (2006.01), A61P 3/10 (2006.01), A61P 41/00 (2006.01), A61P 13/12 (2006.01)
Applicants: XIGEN INFLAMMATION LTD. [CY/CY]; Arch. Makariou III 195 Neocleous House 3030 Limassol (CY)
Inventors: COMBETTE, Jean-Marc; (FR).
DELOCHE, Catherine; (CH)
Agent: GRAF VON STOSCH, Andreas; Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München (DE)
Priority Data:
PCT/EP2013/001881 26.06.2013 EP
PCT/EP2013/001896 27.06.2013 EP
Title (EN) NEW USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
(FR) NOUVELLE UTILISATION D'INHIBITEURS PEPTIDIQUES PERMÉABLES AUX CELLULES DE LA VOIE DE TRANSDUCTION DU SIGNAL JNK POUR LE TRAITEMENT DE DIVERSES MALADIES
Abstract: front page image
(EN)The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of various diseases or disorders strongly related to JNK signaling.
(FR)La présente invention concerne l'utilisation d'inhibiteurs de protéine kinases et en particulier l'utilisation d'inhibiteurs de la protéine kinase c-Jun N-terminal kinase, de séquences inhibitrices de JNK, de peptides chimériques ou d'acides nucléiques codant pour ceux-ci, ainsi que des compositions pharmaceutiques contenant ceux-ci, pour le traitement de divers troubles ou maladies fortement liés à la voie de signalisation JNK.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)